Showing results (731-740 of 1,020) with videos related to
Sort By:
Pageof 102
Cancer Research Communications|July 31, 2023
Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer TherapyMengwu Pan, Valeria Solozobova, Nane C Kuznik, et al.Cancer Research Communications|July 27, 2023
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 BenefitBenjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, et al.Cancer Research Communications|July 24, 2023
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell CarcinomaMoon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, et al.Cancer Research Communications|July 21, 2026
Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain MetastasesMaria J Contreras-Zárate, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz, et al.Cancer Research Communications|June 22, 2026
Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumorsJaime R Merchan, Manish R Patel, Timothy P Cripe, et al.Cancer Research Communications|March 31, 2026
Cooperative roles of class IA PI3K isoforms in translocation-related sarcoma cell survival and proliferationSho Isoyama, Naomi Tamaki, Yutaka Noguchi, et al.Cancer Research Communications|April 17, 2026
Alprazolam reduces inflammatory cytokine production in pancreatic cancer-associated fibroblastsHunter D Reavis, Aditi H Chaubey, Amanda L Smythers, et al.Cancer Research Communications|April 17, 2026
Association between diagnostic history and cancer incidence within 5 years: a real-world observational analysisMd Ashad Alam, Grace Williams, Muhammad G Kibriya, et al.Cancer Research Communications|May 6, 2026
Intravenous Immunoglobulin Reduces Infections for Patients with Chronic Lymphocytic Leukemia: A Single-Center Retrospective AnalysisNirja N Shah, Tulsi Patel, Thomas J Kipps, et al.Cancer Research Communications|April 24, 2026
ALDH+ anaplastic thyroid cancer cells show vulnerability to a pharmacological inducer of centrosome de-clusteringHenry Guanghao Yu, Krikor Bijian, Jie Su, et al.Pageof 102